Potency of a tau fibrillization inhibitor is influenced by its aggregation state
- 1 September 2007
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 465 (1) , 127-135
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and DistinctJournal of Biological Chemistry, 2007
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Cyanine Dye N744 Inhibits Tau Fibrillization by Blocking Filament Extension: Implications for the Treatment of Tauopathic Neurodegenerative DiseasesBiochemistry, 2005
- Site‐specific pseudophosphorylation modulates the rate of tau filament dissociationFEBS Letters, 2005
- Ligand-Dependent Inhibition and Reversal of Tau Filament FormationBiochemistry, 2004
- Pinacyanol as effective probe of fibrillar β‐amyloid peptide: Comparative study with Congo RedBiopolymers, 2003
- Tau Conformational Changes Correspond to Impairments of Episodic Memory in Mild Cognitive Impairment and Alzheimer's DiseaseExperimental Neurology, 2002
- Band-shifting through polypeptide β-sheet structures in the cyanine UV-Vis spectrumBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule bindingNeuron, 1993
- Kinetic Studies of Association and Dissociation Reactions of Congo Red by the Temperature-Jump MethodBulletin of the Chemical Society of Japan, 1972